ezetimibe has been researched along with 1-propanol in 2 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (1-propanol) | Trials (1-propanol) | Recent Studies (post-2010) (1-propanol) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 3,135 | 170 | 345 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCarty, MF | 1 |
| Bellocchio, A; Bertolini, S; Pisciotta, L | 1 |
1 trial(s) available for ezetimibe and 1-propanol
| Article | Year |
|---|---|
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment.
Topics: Aged; Anticholesteremic Agents; Azetidines; Berberine; Biological Products; Cholesterol, LDL; Dietary Supplements; Drug Combinations; Drug Therapy, Combination; Ezetimibe; Fatty Alcohols; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Mutation; Receptors, LDL; Statistics, Nonparametric; Triglycerides | 2012 |
1 other study(ies) available for ezetimibe and 1-propanol
| Article | Year |
|---|---|
An ezetimibe-policosanol combination has the potential to be an OTC agent that could dramatically lower LDL cholesterol without side effects.
Topics: Anticholesteremic Agents; Azetidines; Drug Therapy, Combination; Ezetimibe; Fatty Alcohols; Humans; Lipoproteins, LDL; Nonprescription Drugs | 2005 |